Ultragenyx Pharmaceutical | Omløpsmidler

Current Assets Endring Dato
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
Agios Pharmaceuticals USD 663.63M 170.21M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Insmed USD 758.72M 170.34M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
Kyowa Hakko Kirin JPY 553.64B 57.48B 2024-03
MacroGenics USD 202.58M 48.76M 2024-03
Moderna USD 9.6B 725M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
PTC Therapeutics USD 1.17B 49.89M 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



Ultragenyx Pharmaceutical Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.